Refine
Has Fulltext
- yes (43)
Is part of the Bibliography
- yes (43)
Year of publication
Document Type
- Journal article (43)
Language
- English (43) (remove)
Keywords
- Fabry disease (11)
- neuropathic pain (7)
- fibromyalgia syndrome (6)
- pain (6)
- cytokines (5)
- small fiber neuropathy (4)
- depression (3)
- gene expression (3)
- B7-H1 (2)
- Fabry-associated pain (2)
- Fibromyalgia syndrome (2)
- Mechanisms (2)
- chronic pain (2)
- diagnosis (2)
- enzyme replacement therapy (2)
- globotriaosylceramide (2)
- inflammation (2)
- mouse model (2)
- mouse models (2)
- polyneuropathy (2)
- renal system (2)
- skin punch biopsy (2)
- A-delta fibers (1)
- ALS mimic (1)
- Anxiety (1)
- Arterial Diameters (1)
- Aδ- and C-fibers (1)
- C.376A>G (p.S126G) (1)
- CCI (1)
- CNS imaging (1)
- Capsaicin receptor (1)
- CholinomiRs (1)
- Cognitive behavior (1)
- Cold (1)
- Corneal confocal microscopy (1)
- Cytokines (1)
- El Escorial (1)
- English version (1)
- Expression (1)
- Fabry genotype (1)
- Fabry phenotype (1)
- Factor messenger-RNA (1)
- Gene-expression (1)
- Gland (1)
- Heat Hyperalgesia (1)
- Hyperalgesia (1)
- IL-4 (1)
- Identification (1)
- Immune system (1)
- Innervation (1)
- Interleukin-6 (1)
- Interleukin-6-Deficient mice (1)
- Langerhans cells (1)
- Leukemia Inhibitory Factor (1)
- Mediated Inflammatory Hyperalgesia (1)
- Monopolar depression (1)
- NF-κB (1)
- Necrosis-factor-Alpha (1)
- Nerve growth-factorcopy (1)
- Neurogenic inflammation (1)
- Oncostatin-M-Receptor (1)
- Opioid receptor (1)
- PD-L1 (1)
- PET (1)
- Pain questionnaire (1)
- Pain-related evoked potentials (1)
- Paradoxical heat sensation (1)
- Parkinson's disease (1)
- Peripheral Inflammation (1)
- Pleckstrin homology containing family member 5 (Plekhg5) (1)
- RNA extraction (1)
- Rat Sensory Neurons (1)
- Receptors (1)
- Rheumatoid-Arthritis (1)
- SNI (1)
- Schwann cell (1)
- Schwann-cells (1)
- Sensitivity (1)
- Skin biopsy (1)
- Small fiber neuropathy (1)
- Stimuli (1)
- TNFα (1)
- TRP Channels (1)
- Thermal Hyperalgesia (1)
- X-chromosomal inactivation (1)
- algorithm (1)
- allodynia (1)
- alpha-galactosidase A (1)
- analgesia (1)
- animal behavior (1)
- antagomir (1)
- apheresis technologies (1)
- apheresis-therapeutic (1)
- autophagy (1)
- biomarker (1)
- biopsy (1)
- blood CSF barrier (1)
- blood flow (1)
- blood processing (1)
- brain (1)
- burning pain (1)
- capsaicin (1)
- central nervous system (1)
- cerebral arteries (1)
- cerebrospinal fluid (1)
- cholinergic system (1)
- classification (1)
- clinical phenotype (1)
- cognitive impairment (1)
- coping (1)
- corneal confocal microscopy (1)
- cortical activation (1)
- criteria (1)
- crossover trial (1)
- cutaneous innervation (1)
- cutaneous patch (1)
- diagnosis in Fabry disease (1)
- diagnostic medicine (1)
- differential diagnosis (1)
- disability (1)
- disease model (1)
- epidermis (1)
- expression (1)
- female Fabry patients (1)
- females (1)
- fibromyalgia (1)
- flotillin-1 lipid rafts (1)
- gene variant (1)
- genetics (1)
- genotype/phenotype correlation (1)
- guidelines (1)
- haemostasis (1)
- hernia repair (1)
- hyperalgesia (1)
- immune system (1)
- immunofluorescence (1)
- induced pluripotent stem cells (1)
- innervation (1)
- interference (1)
- intraepidermal nerve fiber density (1)
- ion channels (1)
- ischemic stroke (1)
- learning (1)
- lesions (1)
- long-term pain (1)
- lyso-Gb3 (1)
- lysosomal storage disease (1)
- macrophages (1)
- magnetic resonance imaging (1)
- miR-182-5p (1)
- miR-21 (1)
- miRNA (1)
- miRNA expression patterns (1)
- miRNA polymorphisms (1)
- miRNA-based analgesic (1)
- miRNA-based diagnostics (1)
- mice (1)
- microRNA (1)
- midbrain (1)
- migraine (1)
- mixed fiber neuropathy (1)
- motoneuron disease (1)
- motor neuron disease (1)
- muscle atrophy (1)
- near-infrared spectroscopy (1)
- nerve fibers (1)
- nerve fibres (1)
- nerve ultrasonography (1)
- nerve-fibers (1)
- neuroborreliosis (1)
- neurofilament light chain (1)
- neurological examination (1)
- neurology (1)
- neuropathy (1)
- nociceptor sensitization (1)
- opioid (1)
- opioids (1)
- pain pattern (1)
- pain questionnaire (1)
- pain sensation (1)
- pain-associated behavior (1)
- pain-related evoked potentials (1)
- peripheral nerve involvement (1)
- peripheral neuropathy (1)
- plasma (1)
- polymorphism (1)
- postherpetic neuralgia (1)
- proinflammatory cytokine (1)
- quantitative sensory testing (1)
- qutenza (1)
- regulation (1)
- reinnervation (1)
- religiosity (1)
- risk factors (1)
- scale (1)
- sciatic nerves (1)
- sensory neurons (1)
- shingles (1)
- skin diseases (1)
- skin tumors (1)
- small-fiber neuropathy (1)
- spinal cord (1)
- stroke (1)
- substance-P (1)
- superficial peroneal nerve (1)
- sural nerve (1)
- swimming (1)
- synaptic vesicles (1)
- transient receptor potential vanilloid 1 (TRPV1) (1)
- ultrasound imaging (1)
- validation (1)
- variants of unknown significance (1)
- vasculitis (1)
- white blood cells (1)
- α-Galactosidase A (1)
Institute
- Neurologische Klinik und Poliklinik (41)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (4)
- Medizinische Klinik und Poliklinik I (4)
- Institut für Klinische Epidemiologie und Biometrie (2)
- Institut für Klinische Neurobiologie (2)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für Humangenetik (1)
- Institut für Klinische Transfusionsmedizin und Hämotherapie (1)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
Sonstige beteiligte Institutionen
Highlights
• The GLA variant S126G is not associated with Fabry symptoms in the presented case
• S126G has no effect on α-GAL A activity or Gb3 levels in this patient
• S126G sensory neurons show no electrophysiological abnormalities
Abstract
Fabry disease (FD) is a life-limiting disorder characterized by intracellular globotriaosylceramide (Gb3) accumulations. The underlying α-galactosidase A (α-GAL A) deficiency is caused by variants in the gene GLA. Variants of unknown significance (VUS) are frequently found in GLA and challenge clinical management. Here, we investigated a 49-year old man with cryptogenic lacunar cerebral stroke and the chance finding of the VUS S126G, who was sent to our center for diagnosis and initiation of a costly and life-long FD-specific treatment. We combined clinical examination with in vitro investigations of dermal fibroblasts (HDF), induced pluripotent stem cells (iPSC), and iPSC-derived sensory neurons. We analyzed α-GAL A activity in iPSC, Gb3 accumulation in all three cell types, and action potential firing in sensory neurons. Neurological examination and small nerve fiber assessment was normal except for reduced distal skin innervation. S126G iPSC showed normal α-GAL A activity compared to controls and no Gb3 deposits were found in all three cell types. Baseline electrophysiological characteristics of S126G neurons showed no difference compared to healthy controls as investigated by patch-clamp recordings. We pioneer multi-level cellular characterization of the VUS S126G using three cell types derived from a patient and provide further evidence for the benign nature of S126G in GLA, which is of great importance in the management of such cases in clinical practice.